U.S. Markets open in 1 hr 36 mins

Rosetta Genomics Ltd. (ROSG)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.65+0.24 (+17.02%)
At close: 4:00PM EDT

1.70 +0.05 (3.03%)
Pre-Market: 7:38AM EDT

People also watch
RXIIPSTICLSNOPXACYCC
  • L
    Littleguy
    Littleguy
    We have volume and share price climbing. Still not to the $1.70 secondary price, but up is good.
  • G
    Guerilla Trades
    Guerilla Trades
    Strong buying here. Long!
  • m
    michael
    michael
    ha what a sham. shabby at its best
  • m
    michael
    michael
    this must be the end. 550 shares. now we break a dollar
  • m
    michael
    michael
    they only raised 4million dollars. will dilute again.or done
  • J
    Justin
    Justin
    woah volume
  • L
    Littleguy
    Littleguy
    $4 million market cap. Perhaps they should buy a McD's franchise with the $4 million. At least there would be revenue
  • L
    Littleguy
    Littleguy
    Well, look at that! Even those folks who bought the last secondary at $1.70 are down 20%. Of course they sold right away and just hung onto the options. All upside, no downside.
  • L
    Littleguy
    Littleguy
    Anyone understand the need to authorize more shares and increase the shares in the employee incentive plan? Prospectus doesn't say a thing.
  • m
    michael
    michael
    what a joke...patents?? cant afford to pay employees. think they can afford to defend patents....why make these comical announcement
  • v
    vj
    vj
    Purchase price of PDX was 12 millions ( but 10 million was worthless stocks - The purchase price includes $2.0 million in cash, 500,000 ordinary shares of Rosetta Genomics Ltd., ) So if Mr. Berlin not lying then 2.9 million is not bad a deal.
  • v
    vj
    vj
    just like 2015 and 2016 -
    We have seen an uptick in demand for Reveal primarily due to the ease-of-use of Reveal -Mr Berlin in patent press release.
  • L
    Littleguy
    Littleguy
    $4 million market cap. Last I read, Berlin was being paid $500k annually. 12% of market cap? If he owned the company outright, he wouldn't pay himself this much.
  • v
    vj
    vj
    3rd quarter over. Do we have results for Q1 and Q2 yet ?
  • v
    vj
    vj
    The first half of 2017 will definately be a transformational for Rosetta Genomics like all previous years
    - The 2016 was a transformational for Rosetta Genomics
    - 2015 has been transformational for Rosetta Genomics
    - Throughout the second half of 2014, we continued to make significant progress on our strategic
    -Throughout 2013 we made considerable progress in all three areas critical to long-term revenue
    generation
  • c
    cahir
    cahir
    There’s only one resource out there that has consistently uncovered the best plays from across the markets, check out ExplosiveOTC.com
  • m
    michael
    michael
    must be anither dilution coming..couple of ussless headlines...ken still thinks market is stupid
  • m
    michael
    michael
    but deal calls for only 1.2m now and the balance..come and get it...laying.people off no funds to find buisness never mind funds to chase debts
  • J
    Jake
    Jake
    Ken Berlin is a criminal. Stock is a strong sell, you have been warned on several occasions!